Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Spironolactone helps regrow hair in women with hair loss.

Certain drugs that block specific enzymes can help treat prostate diseases.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Quercetin may help with PCOS symptoms, but more research is needed.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.